Yulia Kuziv

Dr. Yulia Kuziv

Taras Shevchenko National University of Kyiv, Kyiv, Kyyiv, Misto, Ukraine
+1
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2017 in International Journal of Polymer Science
Verified
Journal Article
Open access
PDF file
GTG. Telegeev
G. Telegeev
NKNataliya V. Kutsevol
Nataliya V. Kutsevol
VCV. Chumachenko
V. Chumachenko
ANAntonina Naumenko
Antonina Naumenko
PTP. Telegeeva
P. Telegeeva
YKYulia Kuziv
Yulia Kuziv
Drug targeting to specific organs and tissues is one of the crucial endeavors of modern pharmacotherapy. Controlled targeting at the site of action and reduced time of exposure of nontargeted tissues increase the efficacy of the treatment and reduce toxicity and side effects, improving compliance and convenience. Nanocarriers based on the branched copolymers dextran-graft-polyacrylamide were synthesized and characterized and were tested on phagocytic cells. It was shown that these nanoparticles are actively captured by phagocytic cells and that they are not cytotoxic. The polymer nanoparticles loaded with cisplatin at different concentrations from 0.1 to 10 μg/mL yielded dose-dependent decrease in viability of chronic myelogenous leukemia and histiocytic lymphoma cells. The lowest percentage of viable cells was observed for lymphoma cells (22%). Taking into account the fact that our nanoparticles will act mainly on malignant phagocytic cells and do not affect healthy cells, they can thus potentially be used for the therapeutic treatment of tumor cells having phagocytic activity. The effect of nanosilver on cell viability was lower than the one of polymer/cisplatin composite. The data from the cytotoxic studies indicate that nanosilver induces toxicity in cells. However, when the copolymers were conjugated to both nanosilver and cisplatin, such a nanosystem displayed less cytotoxic effect compared to the conjugates of dextran-polyacrylamide and cisplatin.

1 June 2017 in Journal of Molecular Liquids
Verified
Journal Article
Closed access
VCV. Chumachenko
V. Chumachenko
NKNataliya V. Kutsevol
Nataliya V. Kutsevol
YKYulia Kuziv
Yulia Kuziv
MRM. Rawiso
M. Rawiso
AMA. Marinin
A. Marinin
LBLeonid Bulavin
Leonid Bulavin

26 March 2018 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
OYOleg A. Yeshchenko
Oleg A. Yeshchenko
ANAntonina P. Naumenko
Antonina P. Naumenko
NKNataliya V. Kutsevol
Nataliya V. Kutsevol
DMDaria O. Maskova
Daria O. Maskova
YKYulia Kuziv
Yulia Kuziv
AMAndrey I. Marinin
Andrey I. Marinin

16 April 2018 in Applied Nanoscience
Verified
Journal Article
Closed access
PDF file
NKNataliya V. Kutsevol
Nataliya V. Kutsevol
ANAntonina Naumenko
Antonina Naumenko
YKYulia Kuziv
Yulia Kuziv
VCV. Chumachenko
V. Chumachenko
ISI. Shton
I. Shton
VCV. Chekhun
V. Chekhun

14 October 2018 in BioImpacts
Verified
Journal Article
Open access
PDF file
TMTatiana Matvienko
Tatiana Matvienko
VSViktoriya Sokolova
Viktoriya Sokolova
SPSvitlana Prylutska
Svitlana Prylutska
YKYulia Kuziv
Yulia Kuziv
NKNataliya V. Kutsevol
Nataliya V. Kutsevol
URUwe Ritter
Uwe Ritter
Introduction: The aim of this research was to study the impact of various doxorubicin (Dox)-containing nanofluids, e.g. singlewalled carbon nanotube (SWCNT)+Dox, graphene oxide (GO)+Dox and DextranPNIPAM (copolymer)+Dox mixtures on HeLa cells (human transformed cervix epithelial cells, as a model for cancer cells) depending on their concentration. Methods: Structural analysis of GO+Dox complex was accomplished using Hartree-Fock level of theory in 6-31G** basis set in Gaussian. Dynamic light scattering (DLS), zeta-potential, scanning electron microscopy and confocal laser scanning microscopy were used. The cell viability was analyzed by the MTT assay. Results: The viability of HeLa cells was studied with the MTT assay after the incubation with various Dox-containing dispersions depending on their concentration. The size of the particles was determined by DLS. The morphology of the nanoparticles (NPs) was studied by scanning electron microscopy and their uptake into cells was visualized by confocal laser scanning microscopy. It was found that the Dextran-PNIPAM+Dox nanofluid in contrast to Dox alone showed higher toxicity towards HeLa cells up to 80% after 24 hours of incubation, whereas the SWCNT+Dox and GO+Dox nanofluids at the same concentrations protected cells from Dox. Conclusion: The importance of Dextran-PNIPAM copolymer as a universal platform for drug delivery was established, and the huge potential of Dextran-PNIPAM+Dox NPs as novel anticancer agents was noted. Based on the in vitro study of the SWCNT+Dox and GO+Dox nanofluids, it was concluded that SWCNT and GO NPs can be effective cytoprotectors against the highly toxic drugs.

20 December 2021 in RSC Advances
Verified
Journal Article
Open access
PDF file
OYOleg A. Yeshchenko
Oleg A. Yeshchenko
NKNataliya V. Kutsevol
Nataliya V. Kutsevol
ATAnastasiya V. Tomchuk
Anastasiya V. Tomchuk
PKPavlo Khort
Pavlo Khort
VPVirych Pavlo
Virych Pavlo
AMAndrey I. Marinin
Andrey I. Marinin
A zinc tetraphenylporphyrin photosensitizer/dextran graft polyacrylamide anionic copolymer/Au nanoparticles (ZnTPP/D- g -PAAan/Au NPs) triple hybrid nanosystem has been proposed as a nanodrug for potential photodynamic therapy applications.